The diagnosis of Chronic Obstructive Pulmonary Disease (COPD) is based on symptoms, clinical examination, exposure to risk factors (smoking and certain occupational dusts) and confirming lung airflow obstruction (on spirometry). However, most people with COPD remain undiagnosed and controversies regarding spirometry persist. Developing accurate and reliable automated tests for the early diagnosis of COPD would aid successful management. We evaluated the diagnostic potential of a non-invasive test of chemical analysis (volatile organic compounds -VOCs) from exhaled breath. We applied 26 individual classifier methods and 30 state-of-the-art classifier ensemble methods to a large VOC data set from 109 patients with COPD and 63 healthy controls of similar age; we evaluated the classification error, the F measure and the area under the ROC curve (AUC). The results show that classifying the VOCs leads to substantial gain over chance but of varying accuracy. We found that Rotation Forest ensemble (AUC 0.825) had the highest accuracy for COPD classification from exhaled VOCs.
Introduction
Chronic Obstructive Pulmonary Disease (COPD) is characterised by airflow limitation, which is not fully reversible. The causes are largely attributed to inhaling tobacco smoke, occupational exposure to dust and chemicals, and indoor and outdoor pollution (Rabe et al. 2007 ). COPD is a major public health problem and is the only one of the top five causes of death in the first world that is still rising. It is predicted to become the third leading cause of death by 2030, according to a study published by the World Bank/World Health Organization (WHO, 2008) , and accounts for much chronic illness and morbidity. Yet, the Global initiative Obstructive Lung Disease (GOLD) report by Rabe et al. (2007) admits that COPD remains relatively unknown or ignored by the public as well as public health and government officials.
The current diagnosis of COPD is based on reported symptoms, patient's medical history (particularly exposure to risk factors), clinical examination, and then confirming lung airflow obstruction (spirometry) where Forced Expiratory Volume in 1 second (FEV1) divided by Forced Vital Capacity is less than 0.80 and FEV1 predicted is less than 0.7 . (Rabe et al 2007) Developing accurate and reliable automatic tests for early diagnosis of COPD is crucial for disease management as removing risk factors and early inhaled treatments has been shown to prevent progression, chronic ill health and premature death. (Rabe et al 2007) . The current main test, spirometry, is effort dependent and often performed poorly. It can lead to over diagnosis in the young and underdiagnosis in the elderly. Moreover, it has not been validated in ethnic minorities. (Rabe 2007) . The quest for a reliable biomarker in COPD is ongoing.
The smell of breath has long been linked with illness or physical conditions. Can volatile organic compounds (VOCs), measured from the exhaled breath, be used to identify COPD? Following on from Pauling's (1971) Here we study the diagnostic potential of the chemical signature of the exhaled breath for distinguishing between patients with COPD and healthy controls. We apply a large collection of state-of-the-art classification methods developed within the areas of pattern recognition, machine learning and data mining, with a special focus on classifier ensembles. We applied these methods to the largest data set so far derived from our previous work (Philips et al 2012). We demonstrate that the ensemble methods are superior to the individual classifier methods, resulting in better classification accuracy, F measure and the area under the ROC curve (AUC). Table 1 shows a summary of the classification methods and techniques used in the recent literature on diagnosis of lung disease based on breath samples. While the collection of sources is by no means comprehensive, it reveals that the possibilities offered by modern pattern recognition (Duda et al., 2001; Bishop, 2006) , machine learning (Hastie et al., 2011; Schapire and Freund, 2012) and data mining (Witten and Frank, 2001 ) remain largely unexplored.
Material and Methods

Related work
We applied the software package Weka (Hall, et al., 2009 ); a collection of machine learning algorithms for data mining tasks. Weka contains tools for data pre-processing, classification, regression, clustering, association rules, and visualization. It is also wellsuited for developing new machine learning schemes. Weka is open source software issued under the GNU General Public License, available at http://www.cs.waikato.ac.nz/ml/weka/. The classification methods we examined can be grouped into two large categories: individual classifiers and ensemble classifiers. The individual classifiers can be grouped into tree classifiers, rule classifier and other. Details about each of the classifiers can be found in the literature recommended in Weka. Before we reason about the suitability of various classifier models to the data, we note the problems shared by many data sets in the medical domain.  "Wide" data set are characterised by relatively small number of data points (called also instances or examples) compared to the number of features (attributes). In VOC studies, the number of data points varies between 20 and several hundred (see Table 1 ) while the number of VOCs is typically in excess of 2000.  Sparseness of the data comes from the fact that only a fraction of VOCs are likely to appear on the chemical signature of a breath sample. The remaining VOCs are in too small a quantity to trigger detection. Non-detections may also be a result of malfunctioning equipment.
These properties call for stringent experimental protocols to ensure that the element of serendipity is eliminated.
Participants
COPD patients were identified through hospital and primary care registers. All had previously confirmed obstructive lung disease on spirometry, were prescribed optimal inhaled medication, deemed stable by a respiratory clinician and none reported worsening symptoms within 6 weeks of testing. Healthy controls were drawn from spouses of patients, volunteers from local charity organisations and members of staff with no chest pain, breathlessness, cough nor wheeze on screening questions. Subjects gave written consent and the study was approved by our local ethics committee and registered (ISRCTN 82911859). 182 subjects participated . Following test for normality, baseline numeric variables were compared between the two groups using non-paired t-tests and the Mann Whitney U test. The categorical data were compared with chi square. Table 2 compares the two groups. Three breath samples were taken from each subject, 2 minutes apart. A single background air sample was taken to monitor the ambient air at each sampling period. A commercially available sampler (Bio-VOC®, Markes International Limited, UK) was used to trap the last 129mL of breath from a full exhalation. This was then transferred to a thermal desorption tube containing carbon black sorbent which adsorbed the VOCs. Analysis was then performed using thermal desorption, gas-chromatography and mass spectrometry to extract, separate and identify the VOCs respectively. Details can be supplied. Table 2 suggests that that any of the three variables alone: smoking status, predicted FEV1 or oxygen saturation, can distinguish reliably between COPD and controls with statistical significance p<0.05. Why continue? Our study is aimed at a further discovery of COPD diagnostic indicators. A classifier based solely on VOCs can contribute an 'independent opinion' to the collection of other, more traditional, diagnostic tests and cues. This combination may lead to a more reliable and accurate overall diagnostic tool, capable of detecting early stages of COPD. Below we give a brief comment on some of the individual classifiers included in the experiment  SVM. Since its inception, the support vector machine classifier (SVM) has been gaining strength and is progressively eclipsing many earlier classifier models (Burges, 1998 ). This classifier is particularly suited to wide data type because it scales linearly along the feature dimension while tolerating the small sample size by ensuring large classification margins. SVM has a noticeable presence in the literature on VOCs classification (Table  1) , not only as a classification method, but also as a powerful feature selection technique (Guyon et al., 2006) . The SVM was applied with a linear and with a Gaussian kernel, with parameter values as pre-set in Weka.  Decision tree classifier. This classifier is praised for its accuracy, robustness and interpretability (Breiman et al., 1984) . These properties have prompted the development of many variants, some of which we used in our experiment. J48 is Weka's implementation of the decision tree classifier otherwise known as c4. 5 . This has been a popular choice of a base classifier in classifier ensemble studies.  LDA. The linear discriminant analysis is a robust method for classification, and is commonly applied to biomedical data. We can speculate here that the wide use of LDA is a consequence of its availability in major statistical software packages and its acceptance within the statistics community. More flexible classifiers, backed by no less rigorous theory, may be overlooked in the process. One of the aims of our paper is to alert practitioners to the existence and availability of such methods.  Rule-based classifiers. JRip is a version of a rule-based classifier which learns the geometry of the classes in the data (Cohen et al., 1995) . Many rule-based classifiers exist, but unlike the decision tree family, the rule-base classifiers are not variants of one another, and may follow very different learning strategies.  Neural Networks (NN). We included in the experiment a version of the Multi-Layer Perceptron (MLP) and the Radial Basis Function NN (RBF). One disadvantage of this type of classifier is the need of fine tuning. NNs enjoy a great success in the hands of experts. However, if they are used with the pre-defined parameters (which was our approach) they may not perform up to their full potential.
Classifiers and Classifier Ensembles
Classifier ensembles are now a well established and a widely acclaimed sub-field of pattern recognition, machine learning and data mining (Kuncheva, 2004 (Webb, 2002) . A wealth of experimental work has been published trying to elect a winner among the ensemble methods. However, just like with the individual classifiers, the "No Free Lunch Theorem" holds, which states that no single method can be best on all possible data. This is why we chose all six methods for our study. The classifier ensemble methods are expected to be fairly robust with respect to the base classifier used. However, over the years, the decision tree classifier has been consistently elected as the most suitable base classifier. (Some of the ensemble methods are termed "forest" because of this choice.)
We note here that we have not neglected to include the Random Forest ensemble (Breiman, 2001) , one of the most successful ensemble methods, especially suitable for medical data. This method is equivalent to Bagging with Random Tree as the base classifier (Note 2 in Figure 1 ), which we have included in our set-up.
Experiment
Protocol (i) The experiments were done using a 10 fold cross validation, repeated 10 times.
(ii) The cross validation was additionally indexed by the person identifier. The three records from the same person were placed in the same fold. This was done in order to ensure that the data for the same person did not appear simultaneously in the training and testing sets.
(iii) As a benchmark, we included in the comparisons the Majority classifier (also known as the Largest Prior classifier). This is the trivial classifier which always predicts the majority class label.
(iv) The performance of the classifiers and the ensembles was measured by the classification accuracy, the F measure, and also by the area under the ROC curve (AUC), taking COPD as the positive class. All calculations were done on the 100 testing folds of the 10-times 10-fold cross-validation. To illustrate the calculation, consider the following contingency table In principle, AUC measures the probability that the classifier will assign a higher score to a randomly chosen positive example than to a randomly chosen negative example. Recent studies have questioned the merit of AUC as a measure of classification performance (Hanczar et al., 2010) , especially when the number of data points is not large. Hence we will refrain from offering statistical back up of our findings, and will exercise caution when interpreting the numerical results. In any case, the data was not sampled as i.i.d., hence the prior probability for COPD and healthy control cannot be estimated and used. This "misleads" the classifiers, which will try to accommodate the class prevalence, and therefore speaks in favour of AUC. Thus we decided to use all three measures.
Results
A total of 2075 different VOCs were recorded in samples. Of these, 146 VOCs had zero values for patient samples but were identified in background air samples only, suggesting they were ambient VOCs , leaving 1929 potentially useful VOCs.
Only 253 VOCs were observed in more than 5% of the subjects (in one or more of the three breath samples from the subject). In addition, we considered a measure of 'quality' (certainty) of the VOC detection against a library of standard mass spectra. VOCs whose quality was less than 50% were deemed unreliable. Reasons for a low quality score might be background 'noise' due to their low magnitude, or multiple compounds being insufficiently separated. After removing the low quality VOCs, 128 reliable and commonly detected VOCs remained as the input for the rest of the analyses Tables 3 and 4 show the three measures for the 56 classifiers in the experiment. The values are averaged across the 100 testing folds of the CV. The cells with the largest value of the measure in the respective column are highlighted. To aid the interpretation of the results we included Figures 2 and 3 . Each classification method is plotted as a dot (individual classifiers) or a cross (ensemble classifier). To visualise the relative position of the ensemble model that we recommend -the Rotation Forest -the 5 points corresponding to the different versions are plotted with a square marker.
Since all three performance criteria have their strengths and weaknesses, we derived the Pareto-optimal set of non-dominated classification methods. A classification method is called "non-dominated" if there is no other method in the set that has better or equal values on all criteria, such that at least one of the inequalities is strict. The Pareto optimal set is shown in Table 5 , arranged in alphabetical order of non-dominated methods.
Conclusions:
(1) Classifier ensembles fare better than individual classifiers in diagnosing COPD from VOCs according to all three performance measures but there is no single classification method that is best on all criteria.
(2) The chance AUC value is 0.5. All classifiers clear this value by a large margin, suggesting high accuracy for the VOC classification in diagnosing COPD. The results with the other two performance measures are less impressive, more so for the F-measure.
(3.) The Rotation Forest ensemble (Rodríguez et al, 2006) achieves the highest value of the F-measure and the second highest for AUC, leading us to recommend this classification method for future analyses. The recommended base classifier is the rule-based classifier JRip (Cohen et al., 1995) . However, the points for the Rotation Forest ensemble are closely clustered in Figures 2 and 3 , which indicates that the method is reasonably robust to the choice of base classifier. 
Discussion
Due to the technicality of trapping and VOC measurements in specialist laboratories, it is not yet clear whether VOC measurement and classification will contribute significantly to the routine diagnosis or monitoring of COPD. Future studies are needed to assess the "value for money" of VOC classification when combined with the traditional diagnostic tests.
However, this study helps advance new possibilities by pointing at the rich and unexplored yet armoury of methods offered by modern pattern recognition, machine learning and data mining. Many of these methods can be used as off-the-shelf classifiers, requiring minimal parameter tuning, if any. Although lacking interpretability (a common characteristic of the most powerful classification methods, for example, classifier ensembles), these methods can be used safely and reliably in the form of black boxes by non-specialist users. The user's trust will come from the clean and rigorous experimental protocol where the work of the methods will be assessed on unseen data.
With the development of modern technology, electronic noses and devices for VOC analysis may become an inexpensive tool available to the general practitioners and home monitoring. Exhaled breath analysis is non-invasive; it is a smaller and portable test, and involves no radiation exposure (unlike X-rays or computer tomography scanning). Unlike spirometry, VOCs analysis is not effort dependent.
Future research should focus on securing a clean and reliable data set by improving trapping and measuring techniques to reduce contamination and increase the number and the 'quality' ratings of the VOCs. This will lead to a larger number of useful VOCs, and hopefully a better classification performance. It is worth developing a stand-alone software tool allowing researchers and practitioners to experiment directly with the most successful ensemble methods discovered in our analyses.
